Original Research
Published on 07 Jun 2024
A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1397029
- 3,847 views
Type at least 3 characters
396 articles
Articles
Data Report
Published on 06 Jun 2024
The last 3 decade of vaccination coverage in the Balkan and Eastern Europe countries with reference to the impact of the COVID-19 pandemic
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1278771
- 3,492 views
Original Research
Published on 05 Jun 2024
Comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events—a real-world longitudinal inception cohort study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1357567
- 992 views
Original Research
Published on 05 Jun 2024
Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385036
- 2,503 views
Original Research
Published on 31 May 2024
Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370661
- 1,833 views
- 1 citation
Original Research
Published on 30 May 2024
A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1368244
- 1,613 views
- 1 citation
Original Research
Published on 27 May 2024
Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1256649
- 4,961 views
- 1 citation
Original Research
Published on 23 May 2024
Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1379251
- 1,284 views
- 1 citation
Original Research
Published on 23 May 2024
Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376494
- 2,074 views
Original Research
Published on 22 May 2024
COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1374320
- 13,356 views
Original Research
Published on 13 May 2024
Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1372401
- 2,193 views
Original Research
Published on 09 May 2024
Assessing the safety of bedaquiline: insight from adverse event reporting system analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1382441
- 1,674 views
Original Research
Published on 09 May 2024
Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389814
- 2,025 views
- 1 citation
Original Research
Published on 29 Apr 2024
Association between atorvastatin and erectile dysfunction: a comprehensive analysis incorporating real-world pharmacovigilance and Mendelian randomization
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1382924
- 11,170 views
Original Research
Published on 24 Apr 2024
Assessment of antimicrobial prescribing patterns, guidelines compliance, and appropriateness of antimicrobial prescribing in surgical-practice units: point prevalence survey in Malaysian teaching hospitals
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1381843
- 2,517 views
- 2 citations
Perspective
Published on 18 Apr 2024
Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia’s perspective
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376009
- 1,743 views